Table 6 Descriptive characteristics of 33 patients involved in three nosocomial outbreaks
Variable | Number (%) |
|---|---|
Length of hospital stay (days) | |
  ≤ 7 | 6.1 (2/33) |
 8–14 | 9.1 (3/33) |
 15–21 | 24.2 (8/33) |
  > 21 | 60.6 (20/33) |
Age (years) | |
  < 40 | 6.1 (2/33) |
 40–59 | 33.3 (11/33) |
 60–79 | 51.5 (17/33) |
  ≥ 80 | 9.1 (3/33) |
Outcome of the patients | |
 Death | 12.1 (4/33) |
Antibiotic intakea | |
 Cephalosporins | 42.4 (14/33) |
 Carbapenem | 24.2 (8/33) |
 β-lactam/β-lactamase inhibitor combinations | 36.4 (12/33) |
 Quinolones | 15.2 (5/33) |
 Glycopeptides | 12.1 (4/33) |
 Aminoglycosides | 0 (0/33) |
 Macrolides | 0 (0/33) |
 Lincosamides | 0 (0/33) |
 Trimethoprim-Sulfamethoxazole | 0 (0/33) |
Comorbid diseases | |
 Cerebrovascular event | 39.4 (13/33) |
 Chronic obstructive pulmonary disease | 36.4 (12/33) |
 Malignant diseases | 21.1 (7/33) |
 Diabetes mellitus | 9.1 (3/33) |
 Chronic renal failure | 6.1 (2/33) |
 Heart failure | 3.0 (1/33) |